Google Search

Search

Already a Member ?

IV Fluids, I.V. solutions, Intravenous fluids, Normal Saline (NS, 0.9NaCl, or NSS), Lactated Ringers (LR, Ringers Lactate, or RL), Dextrose 5%, Normal Saline (Half Normal Saline, 0.45NaCl, .45NS), IV Fluids & Dialysis products - LVP/SVP Volume Parenteral

 

I V Fluids

Intravenous therapy (IV) is therapy that delivers fluids directly into a vein. The intravenous route of administration can be used both for injections, using a syringe at higher pressures; as well as for infusions, typically using only the pressure supplied by gravity. Intravenous infusions are commonly referred to as drips.

The intravenous route is the fastest way to deliver medications and fluid replacement throughout the body, because they are introduced directly into the circulation. Intravenous therapy may be used for fluid volume replacement, to correct electrolyte imbalances, to deliver medications, and for blood transfusions.

Infusion therapy as a basic toll of modern medical care enables the physician to restore and stabilize homeostasis states quickly and completely. In nursing homes and hospital where patients are suffering from acute dehydration or considerable debilitating conditions, the intra venous fluids are used as I.V. drips. The basic function of I.V. fluids is to replenish the body fluids. Although there are number of I.V. fluids, but generally three types of I.V. fluids are used in hospitals as I.V. drips. 1. Dextrose injection fluid. 2. Dextrose and sodium chloride injection fluid. 3. Sodium Chloride injection solution (Saline solution). Dextrose solution is used during postoperative period when sodium extraction of 10-15% are used as diuretic for increasing in urine flow. Saline solution is used when large amount of sodium has been lost by vomiting or by gastric or intestinal duodenal aspiration or through an alimentary fistula. Dextrose monohydrate is used as supplement to cow’s milk in part of feeding. Hypertonic dextrose solution (25-50%) is in medical treatment partly because they are believed to strengthen heart muscles. Hypertonic solutions are used in intravenous injection to relieve intractable pressure in-patient with hydrocephalus and meningitis. The drug industry has now achieved an impressive growth during the last four decades of planning and development. These I.V. fluids are the best alternative, which can yield sudden result in the health of a Patient by replenishing the body fluids.

Intravenous solutions have evolved with technologies and designs improving their overall functionalities. There are several combinations of packaged intravenous products that have come up in recent years. Manufacturers are introducing IV fluids and compounds that can be mixed with other liquid medicines and solutions for IV administration. The aforementioned factors will continue to drive the global intravenous (IV) solution market.  Some of the factors that are having positive impact on the growth of the intravenous (IV) solution market include increased prevalence of chronic disorders and growing popularity of IV led treatments and therapies intended towards curing cance.

Uses and Applications

There are main ranges of application of highly specialized intravenous infusion solutions:

• Treatment of discarded water and electrolyte metabolism, especially in severe cases.

• Therapy of acid base in balances.

• The volume substitution and volume replacement in surgery of accident victim suffering blood loss.

• Paratral nutrition for severally ill and post-operative patients.

Aqueous isotonic injection (5%) of dextrose is given as intravenous injections to increase the column of circulating blood in the shocks and hemorrhages and to counteract dehydration. When it is desired to replace excessive salt loss also glucose is injected along with sodium chloride. Intravenous fluids can also be used as a route of medication administration. If a doctor wants to delI.V.er a small amount of medication over an extended period of time, it can be dissolved in a bag of intravenous fluids and set on an infusion pump which delivers the medicated fluid directly into the blood.

They are also commonly used to assist with surgical recovery; people who receive fluids after surgery tend to experience better recovery than people who do not.

Global Intravenous Solutions Market Trends:

Over the past few years, the prevalence of hectic work schedules and unhealthy lifestyles has increased across the globe. The consequent decline in physical activity and proper nutrition has led to a rise in the incidences of chronic diseases, which in turn has boosted the demand for intravenous solutions. Besides, there has been significant growth in the production of IV fluids, particularly in developed countries. For instance, it was reported that due to the shortage of IV saline, the US Food and Drug Administration (FDA) and other market. The intravenous fluid bags market size will grow at a CAGR of 6% at an incremental growth of $ 667.51 MN during 2020-2024.

The increasing prevalence of chronic diseases such as the rise of cholera and growing acceptance of vitamin c intravenous for colorectal cancer are the major drivers propelling market growth. However, the presence of stringent government regulations, rising continuous demand for IV solutions in the US, and increasing vitamin C intravenous therapy prices constrain the growth of the market.

The rising number of surgeries, the need for a faster route of drug administration, growing preference for single-dose administration of vaccines and drugs, and an increase in local manufacturing is expected to drive the market for LVP. Parenteral route of administration helps provide an accurate dose of medication as the majority of the drug is directly absorbed in circulation, bypassing the gastrointestinal tract.

The drug serum level increases rapidly through parenteral administration. For instance, postoperative parenteral nutrition induces a substantial increase in serum leptin within six hours and helps reach a rise of more than four folds within 14 hours. Moreover, parenteral administration of ascorbate (Vitamin C) decreases the growth rate of murine hepatoma. However, oral administration of the same dosage does not exhibit similar anti-tumoral effects.

Advantages of BFS Technology:

Blow-fill-seal technology enables the manufacture of preservative-free single-unit doses. PreservatI.V.es are recognized as potentially harmful to the sensitive mucosae of the eyes, nose, and lungs, so this is an enormous benefit to sensitive patients. Another advantage of unit-doses is that they ensure that the patient takes the correct amount of product, especially when dealing with highly potent compounds, i.e. those therapeutically active at a low concentration.

Sterile unit-doses are portable and easy to use individually, excellent properties for today’s active lifestyles. Blow-fill-seal (BFS) single doses are an ideal solution for use in ophthalmology, respiratory diseases, rhinology, and antisepsis and wound care. Blow-fill-seal technology reduces personnel intervention making it a more robust method for the aseptic preparation of sterile pharmaceuticals. BFS is used for the filling of vials for parenteral preparations and infusions, eye drops, and inhalation products. Generally the plastic containers are made up of polyethylene and polypropylene. Polypropylene is more commonly used to form containers which are further sterilized by autoclaving as polypropylene has greater thermo stability.

Blow Fill and Seal technology is mainly used for pharmaceutical solutions. The examples of pharmaceutical solutions that can be packaged are injectable solutions, antibiotics, ophthalmological drops, suspensions, infusion solutions, solutions for dialysis, solutions for irrigation and solutions for hemofiltration. The basic concept of BFS is that a container is formed, filled, and sealed in a continuous process without human intervention, in a sterile enclosed area inside a machine. Thus this technology can be used to aseptically manufacture sterile pharmaceutical liquid dosage forms.

The process is multi-stepped: first, pharmaceutical-grade plastic resin is vertically heat extruded through a circular throat to form a hanging tube called the parison. This extruded tube is then enclosed within a two-part mould, and the tube is cut above the mould. The mould is transferred to the filling zone, or sterile filling space, where filling needles (mandrels) are lowered and used to inflate the plastic to form the container within the mould. Following the formation of the container, the mandrel is used to fill the container with liquid. Following filling the mandrels are retracted and a secondary top mould seals the container. All actions take place inside a sterile shrouded chamber inside the machine. The product is then discharged to a non-sterile area for labeling, packaging and distribution. The process begins with the Extrusion of plastic granules in the form of a hot hollow pipe of molten plastic called a parison.

The following step is the Blow molding of the container from the plastic granule. The parison is closed between the mould, and the container gets formed either by blowing sterile compressed air or by vacuum or by using vacuum as well as blowing. The container assumes the shape of the cavity in the mould. The container thus produced is open from the top and in its top part, the plastic is still hot and in molten state until the subsequent steps of filling and container sealing.

Features:

1. 100% film utilization: No waste edge between bags, reducing both material and energy consumption.

2. Special I.V. bag design: each bag saves 10mm film than others.

3. Reliable heating and welding system: Leakage rate less than 0.03%.

4. Quick changeover: 0.5-1 hour to switch from one size to another.

5. Stable transmission system: only needs 1 control system, 1 HMI and 1 operator.

6. Safe filling nozzle: No solution overflows, no particles generation.

7. Auto faulty rejection system detected by the machine.

8. Production line length is reduced by 1/3, both workshop and air conditioning and cleaning area are reduced by 1/3, greatly reducing the initial investment and future running cost.

9. Simple structure, more stable and reliable performance.

 

 

 

Reasons for buying our reports:

This report helps you to identify a profitable project for investing or diversifying into by throwing light to crucial areas like industry size, market potential of the product and reasons for investing in the product

This report provides vital information on the product like its characteristics and segmentation

This report helps you market and place the product correctly by identifying the target customer group of the product 

This report helps you understand the viability of the project by disclosing details like machinery required, project costs and snapshot of other project financials

The report provides a glimpse of government regulations applicable on the industry

The report provides forecasts of key parameters which helps to anticipate the industry performance and make sound business decisions.

 

Our Approach:

Our research reports broadly cover Indian markets, present analysis, outlook and forecast for a period of five years.

The market forecasts are developed on the basis of secondary research and are cross-validated through interactions with the industry players

We use reliable sources of information and databases. And information from such sources is processed by us and included in the report


 

 

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 4 of 5 | Total 49 projects in this category
« Previous   Page 1 2 3 4 5   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Liquid Glucose From Broken Rice

Liquid Glucose is usually manufactured by subjecting starch to high temperature in the presence of acid. However, Liquid Glucose of same Dextrose Equivalent can be manufactured by enzymatic conversion but the spectrum of saccharides will differ and so also the properties, in comparison to acid converted Liquid Glucose. Liquid Glucose is an aqueous solution of nutritive saccharide obtained by starch hydrolysis, by using Corn and Rice as raw material, which is purified and concentrated to required solids. It is usually odorless and clear yellow colored viscous liquid sweet syrup which is processed and stored under hygienic conditions. Broken rice is the by-product of rice mill. It has various uses out of which one use is to prepare liquid glucose from broken rice. About 90% of the liquid glucose produced in India is consumed by the confectionery industry. Its preparation of sugar candy. It standard confectionery being about 33%. It is used also in textile printing and in biscuit and tobacco canning. The rest of this is used in leather, textile pharmaceutical and other industries. The domestic demand for liquid glucose had been estimated as 10000 MT/annum of which 7500 tones are used in the confectionery plants and are therefore widely distributed in their crude from. Which facilitates the development of new technologies and ensure a high quality product
Plant capacity: Liquid Glucose: 140 MT/DayPlant & machinery: Rs 1267 lakhs
Working capital: -T.C.I: Cost of Project: Rs 2275 lakhs
Return: 25.00%Break even: 43.00%
Add to Inquiry Add to Inquiry Basket

Liquid Glucose from Potatoes

Potato is widely consumed as food all over the world. It contains the starch as a major carbohydrate. Surplus and cull potatoes are used as feed for livestock and also as raw material for the manufacture of starch, ethyl alcohol and a few other industrial products like, dextrose, liquid Glucose etc. Glucose syrup is a sweetening liquid which is made after the hydrolysis of glucose molecule, generally corn, rice, wheat and potato is taken to make glucose syrup because they are a rich source of starch. Glucose syrup is used for making frozen dessert and candy. Glucose syrup are also used to make baked food items to add sweetness. Glucose syrup are generally free from fat, but contains high amount of calories. Glucose syrup made from cornstarch contains a small amount of thiamine, zinc as well as calcium. The Global Market for Glucose Syrup has witnessed continued demand during the last few years and is projected to reach 29,888 kilo tons by 2022, at a CAGR of 3.6% from 2016 to 2022. Raise in demand across various industries such as food and beverage, pharmaceuticals, confectionery are driving the global glucose syrup market. Asia-Pacific region is estimated to dominate the global glucose syrup market holding a lion’s share of more than 30% accounting for a market volume of more than 10,000 kilo tons. North America will witness the highest growth rate of 3.94% in the global glucose syrup market whereas Europe and Rest of the world will witness moderate growth rate.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

IV Fluids (BFS Technology)

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Intravenous fluids can also be used as a route of medication administration. If a doctor wants to deliver a small amount of medication over an extended period of time, it can be dissolved in a bag of intravenous fluids and set on an infusion pump which delivers the medicated fluid directly into the blood. The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. However, the Indian industry, valued at USD 17 bn in represented just over 1% of the global pharmaceutical industry (USD 1700 bn) in value terms. The domestic market is estimated at Rs 680 bn. Intravenous (IV) fluids market in India is around Rs. 3,000 crore growing at healthy rate of around 15-20 per cent a year due to its essential requirement in nature. Entrepreneurs who invest in this project will be successful. Few Indian major players are as under • Abaris Healthcare Pvt. Ltd. • AhlconParenterals (India) Ltd. • AxaParenterals Ltd. • Infutec Healthcare Ltd. • Kokad Pharmaceutical Laboratories Ltd. • Parenteral Surgicals Ltd.
Plant capacity: IV Fluids (500 ml Bottle): 49600 Pcs./DayPlant & machinery: Rs. 1954 lakhs
Working capital: -T.C.I: Cost of Project: Rs. 2756 lakhs
Return: 25.00%Break even: 52.00%
Add to Inquiry Add to Inquiry Basket

IV Fluids (BFS Technology)

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Intravenous fluids can also be used as a route of medication administration. The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Entrepreneurs who invest in this project will be successful.
Plant capacity: IV Fluids (500 ml Bottle): 40000 Pcs/day Plant & machinery: Rs 2734 lakhs
Working capital: -T.C.I: Cost of Project: Rs 3712 lakhs
Return: 26.00%Break even: 48.00%
Add to Inquiry Add to Inquiry Basket

IV Fluids in Plastic Bottles (IV Solution Automatic System)

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use.The basic function of IV fluids is to replenish the body fluids.Intravenous fluids can also be used as a route of medication administration. The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.Entrepreneurs who invest in this project will be successful. Few Indian major players are as under • Abaris Healthcare Pvt. Ltd. • AhlconParenterals (India) Ltd. • AxaParenterals Ltd. • Infutec Healthcare Ltd. • Kokad Pharmaceutical Laboratories Ltd. • Parenteral Surgicals Ltd.
Plant capacity: IV Fluids (500 ml Bottle): 40000 Pcs./dayPlant & machinery: Rs. 2658 lakhs
Working capital: -T.C.I: Cost of Project: Rs10817 lakhs
Return: 17.00%Break even: 25.00%
Add to Inquiry Add to Inquiry Basket

Saline and Dextrose Fluid (IV)

Saline is a general phrase referring to a sterile solution of sodium chloride in water, but is only sterile when it is to be placed parenterally; otherwise, a saline solution is a salt water solution. The sterile solution is typically used for intravenous infusion, rinsing contact lenses, nasal irrigation, and often used to clean a new piercing. Dextrose Solution (5%) is an isotonic solution and supplies calories to human body instantaneously without disturbing the electrotype balance. The global Intravenous (IV) solutions market was valued at USD 6.9 billion in 2015 and is projected to grow at a CAGR of 7.8% over the forecast period. And is expected to reach a value of USD 13.79 billion by 2024. As a whole there is a good scope for new entrepreneur to invest in this business. Few Indian major players are as under • Amanta Healthcare Ltd. • Axa Parenterals Ltd. • Infutec Healthcare Ltd. • Kokad Pharmaceutical Laboratories Ltd. • Parenteral Drugs (India) Ltd. • Parenteral Surgicals Ltd.
Plant capacity: Dextrose IV Fluid (100 ml Size) : 7800 Bottles/Day Dextrose-Sodium Chloride IV Fluid (250 ml Size): 7200 Bottles/Day Sodium Chloride IV Fluid (500 ml Size): 6200 Bottles/Day Ciprofloxacin (100 gm Size) Bye Product: 250 Bottles/Day FluconazolPlant & machinery: Rs 2281 lakhs
Working capital: -T.C.I: Cost of Project: Rs 3200 lakhs
Return: 28.00%Break even: 34.00%
Add to Inquiry Add to Inquiry Basket

IV Fluids (BFS Technology)

In nursing homes and hospital where patients are suffering from acute dehydration or considerable debilitating conditions, the intra venous fluids are used as IV drips. The basic function of IV fluids is to replenish the body fluids. Although there are a number of IV fluids but generally three types of IV fluids are used in hospitals as IV drips. Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenous administration. Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids when they are sick, to keep their fluid volume stable. The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation. These fluids are sterile fluids which protects patients at the time of serious dehydration. There are various type of IV solutions available for use in the market. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The global Intravenous (IV) solutions market was valued at USD 6.9 billion in 2015 and is projected to grow at a CAGR of 7.8% over the forecast period. The emergence of this market is attributed to the fast growing geriatric population and prevalence of malnutrition in the elderly and pediatric population. ? Few Indian major players are as under: • Abaris Healthcare Pvt. Ltd. • Ahlcon Parenterals (India) Ltd. • Axa Parenterals Ltd. • Infutec Healthcare Ltd. • Kokad Pharmaceutical Laboratories Ltd. • Parenteral Surgicals Ltd. • Pharmazell (India) Pvt. Ltd.
Plant capacity: IV Fluids (500 ml Size Pack):55,000 Packs per day IV Fluids (200 ml Size Pack):65,000 Packs per dayPlant & machinery: 2543 Lakh
Working capital: -T.C.I: Cost of Project:3277 Lakh
Return: 28.00%Break even: 42.00%
Add to Inquiry Add to Inquiry Basket

Manufacturing of I.V. Fluids (BFS Technology).

Production of I.V. Fluids (BFS Technology). Profitable Business of Intravenous Solutions, Intravenous Fluids. Intravenous fluids are fluids that are supposed to be administered to a patient intravenously, directly through the circulatory system. These fluids should be sterile to protect patients from injury, and there are variety of various varieties out there to be used. Intravenous fluids also can be used as a route of medication administration. If a doctor wants to deliver a small quantity of medication over an extended period of your time, it will be dissolved {in adoring in an exceedingly in a very} bag of intravenous fluids and set on an infusion pump that delivers the medicated fluid directly into the blood. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Advantages of BFS Technology: ? Blow-fill-seal technology enables the manufacture of preservative-free single-unit doses. PreservatI.V.es are recognized as potentially harmful to the sensitive mucosae of the eyes, nose, and lungs, so this is an enormous benefit to sensitive patients. ? Another advantage of unit-doses is that they ensure that the patient takes the correct amount of product, especially when dealing with highly potent compounds, i.e. those therapeutically active at a low concentration. ? Sterile unit-doses are portable and easy to use individually, excellent properties for today’s active lifestyles. Blow-fill-seal (BFS) single doses are an ideal solution for use in ophthalmology, respiratory diseases, rhinology, and antisepsis and wound care. ? Blow-fill-seal technology reduces personnel intervention making it a more robust method for the aseptic preparation of sterile pharmaceuticals. BFS is used for the filling of vials for parenteral preparations and infusions, eye drops, and inhalation products. Generally the plastic containers are made up of polyethylene and polypropylene. Polypropylene is more commonly used to form containers which are further sterilized by autoclaving as polypropylene has greater thermo stability. ? Blow Fill and Seal technology is mainly used for pharmaceutical solutions. The examples of pharmaceutical solutions that can be packaged are injectable solutions, antibiotics, ophthalmological drops, suspensions, infusion solutions, solutions for dialysis, solutions for irrigation and solutions for hemofiltration. ? The basic concept of BFS is that a container is formed, filled, and sealed in a continuous process without human intervention, in a sterile enclosed area inside a machine. Thus this technology can be used to aseptically manufacture sterile pharmaceutical liquid dosage forms. Features: 1. 100% film utilization: No waste edge between bags, reducing both material and energy consumption. 2. Special I.V. bag design: each bag saves 10mm film than others. 3. Reliable heating and welding system: Leakage rate less than 0.03%. 4. Quick changeover: 0.5-1 hour to switch from one size to another. 5. Stable transmission system: only needs 1 control system, 1 HMI and 1 operator. 6. Safe filling nozzle: No solution overflows, no particles generation. 7. Auto faulty rejection system detected by the machine. 8. Production line length is reduced by 1/3, both workshop and air conditioning and cleaning area are reduced by 1/3, greatly reducing the initial investment and future running cost. 9. Simple structure, more stable and reliable performance. Related Videos: - https://bit.ly/2UI2SEL Uses and Applications ? There are four main ranges of application of highly specialized intravenous infusion solutions: ? Treatment of discarded water and electrolyte metabolism, especially in severe cases. ? Therapy of acid base in balances. ? The volume substitution and volume replacement in surgery of accident victim suffering blood loss. ? Paratral nutrition for severally ill and post-operative patients. ? Aqueous isotonic injection (5%) of dextrose is given as intravenous injections to increase the column of circulating blood in the shocks and hemorrhages and to counteract dehydration. When it is desired to replace excessive salt loss also glucose is injected along with sodium chloride. ? Dextrose solution is used during postoperative period when sodium extraction is reduced. ? Dextrose solution with concentration of 10-15% is used as diuretic for increase in urine flow. ? Dextrose solutions of 5% normal saline are used for restoring fluid volume in circulation of an emergency as in accidents with hemorrhage. ? Saline solution is used when large amount of sodium has been lost by vomiting or by gastric or intestinal duodenal aspiration or through an alimentary fistula. ? Dextrose monohydrate is used as supplement to cow's milk in part of feeding. ? Hypertonic dextrose solution (25-50%) is in medical treatment partly because they are believed to strengthen heart muscles. Hypertonic solutions are used in intravenous injection to relieve intractable pressure in-patient with hydrocephalus and meningitis. Market Outlook Technologies utilized in the production of IV fluids are Blow-Fill-Seal (BFS) Technology and type fill seal (FFS) technology. BFS and FFS are a variety of advanced aseptic manufacturing technique, in which the container is created (in case of BFS and in FFS pouch is formed), filled, and sealed in one continuous, automated system. A primary advantage of those technologies is to reduce human intervention, which is able to reduce the risk of microorganism contamination and foreign particulates. Thus, these technologies are wont to aseptically manufacture sterile pharmaceutical liquid. Related Videos: - Production of I.V. Fluids (Saline and Dextrose) IV Fluids (FFS) Technology I.V. (Intravenous Liquids) Fluids Manufacturing Unit. The primary costumers for these manufacturing units are Hospitals, Clinics, Dialysis centers, Home care settings. The global Intravenous Fluid market size was valued at US$ 8,372.0 million in 2019 and is expected to witness a CAGR of 6.1% over the forecast period (2019 – 2027). The emergence of the IV Fluid market is attributed to the fast-growing geriatric population and the presence of malnutrition in the elderly and pediatric population. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks Increasing launches and regulatory approvals for Intravenous Fluid injection is expected to drive the growth of the global Intravenous fluid market. Launches of new Intravenous fluid injections for the treatment of various diseases such as dehydration, gastrointestinal diseases are expected to drive the Intravenous fluid market growth Demand & Market Growth Rates of I.V. Fluid Sets in India: Past and Future Year Bottles in Million 2015-16 2885 2016-17 3210 2017-18 3570 2018-19 3945 2019-20 4375 2024-25 7200 COST ESTIMATION Six Cavity 500 ml Bottles : 39,600 Bottles per Day Eight Cavity 500 ml Bottles : 30,800 Bottles per Day Cost of Machinery : Rs. 46,50,0000 Key Players:- ? Abaris Healthcare Pvt. Ltd. ? Ahlcon Parenterals (India) Ltd. ? Axa Parenterals Ltd. ? Infutec Healthcare Ltd. ? Kokad Pharmaceutical Laboratories Ltd. ? Parenteral Surgicals Ltd. ? Pharmazell (India) Pvt. Ltd. Tags:- #IVFluids #IntravenousFluids #Fluid #ivbottles #Intravenous #IVtherapy #businessopportunity #projectreport #DetailedProjectReport #businessconsultant #businessfeasibilityreport #BusinessPlan #startyourbusiness #investmentopportunity #growyourbusiness #startups #pharmaceutical #pharma #pharmaceuticalbusiness #Pharmacy #PharmaceuticalReport #pharmaceuticalprojects
Plant capacity: 70,400 Bottles per DayPlant & machinery: 465 Lakhs
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

IV Fluids (BFS Technology)

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenous administration. Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids when they are sick, to keep their fluid volume stable. Another cause is blood loss, which causes problems both because people lose blood products, and because they experience a loss in fluid volume. Electrolyte levels in the blood can also become unstable as a result of rapid changes in fluid volume, in which case intravenous fluids can be used to restore the balance. The global Intravenous (IV) solutions market was valued at USD 6.9 billion in 2015 and is projected to grow at a CAGR of 7.8% over the forecast period. The emergence of this market is attributed to the fast growing geriatric population and prevalence of malnutrition in the elderly and pediatric population. Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation. These fluids are sterile fluids which protects patients at the time of serious dehydration. There are various type of IV solutions available for use in the market. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. This is attributed to the factors such as Growing acceptance of vitamin C intravenous for Colorectal Cancer and increasing prevalence of the chronic diseases. Europe is the second largest market which is growing at a CAGR of 8.12% from 2016-2022. Asia-Pacific region is the fastest growing market for IV Solutions, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022. As a whole any entrepreneur can venture in this project without risk and earn profit.
Plant capacity: IV Fluids (500 ml Pack): 22,400 Packs / Day IV Fluids (250 ml Pack): 22,400 Packs / DayPlant & machinery: Rs 2505 lakhs
Working capital: -T.C.I: Cost of Project: Rs 4334 lakhs
Return: 27.00%Break even: 42.00%
Add to Inquiry Add to Inquiry Basket

IV Fluids (BFS Technology)

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenous administration. Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids when they are sick, to keep their fluid volume stable. Another cause is blood loss, which causes problems both because people lose blood products, and because they experience a loss in fluid volume. Electrolyte levels in the blood can also become unstable as a result of rapid changes in fluid volume, in which case intravenous fluids can be used to restore the balance. Intravenous fluids can also be used as a route of medication administration. If a doctor wants to deliver a small amount of medication over an extended period of time, it can be dissolved in a bag of intravenous fluids and set on an infusion pump which delivers the medicated fluid directly into the blood. They are also commonly used to assist with surgical recovery; people who receive fluids after surgery tend to experience better recovery than people who do not. Intravenous (IV) solutions are fluids that are intended to be administered to a patient directly into the venous circulation. These fluids are sterile fluids that protects patients at the time of significant dehydration. There are various kind of IV solutions on the market to be used within the market. Several companies manufactures repacked intravenous fluids or product or compounds which may be mixed with sterile water to prepare a solution for intravenous administration. Technologies utilized in the production of IV fluids are Blow-Fill-Seal (BFS) Technology and type fill seal (FFS) technology. BFS and FFS are a variety of advanced aseptic manufacturing technique, in which the container is made (in case of BFS and in FFS pouch is formed), filled, and sealed in one continuous, automated system. A primary advantage of these technologies is to reduce human intervention, which is able to cut back the risk of microbial contamination and foreign particulates. Thus, these technologies are used to aseptically manufacture sterile pharmaceutical liquid. The primary costumers for these manufacturing units are Hospitals, Clinics, Dialysis centers, Home care settings. The global Intravenous Fluid market size was valued at US$ 8,372.0 million in 2019 and is expected to witness a CAGR of 6.1% over the forecast period (2019 – 2027). The basic function of I.V. fluids is to replenish body fluids. It can also be used in the treatment of electrolyte metabolism, especially in severe cases, therapy of acid-base in balances, the volume substitution and volume replacement in surgery of accident victims suffering blood loss. It can be used as parenteral nutrition for severally ill and post-operative patients. The emergence of the IV Fluid market is attributed to the fast-growing geriatric population and therefore the presence of deficiency disease within the old and pediatric population. Increasing launches and regulative approvals for intravenous Fluid injection is expected to drive the growth of the worldwide intravenous fluid market. Launches of latest intravenous fluid injections for the treatment of assorted diseases similar to dehydration, gastrointestinal diseases are expected to drive the intravenous fluid market growth. The growth of the worldwide intravenous solutions market is driven by several factors. The increasing incidence of gastrointestinal disorders, diabetes, and cancer is one in every of the most important factors that are expected to increase the rate of adoption of intravenous solutions among customers. The rising popularity of intravenous vitamin c medical care in cancer treatment is one in all the most important trends in the intravenous solutions market. The intravenous vitamin c solution has been observed to possess an increased toxicity to cancer cells and improve the patients' quality of life. Major drivers of the global intravenous solutions market include increase in the incidence of chronic and acute diseases, rise in the geriatric population, increase in strategic collaborations between manufacturers to enhance their product portfolio and geographical presence, expansion in the pharmaceutical industry, increase in demand for intravenous solutions from developing economies, and increase in health care expenditure. However, factors such as stringent regulatory scenario and high cost of maintenance of fluids are expected to restrain the global intravenous solution market during the forecast period. As a whole any entrepreneur can venture in this project without risk and earn profit. Few Indian major players are as under Parenteral Surgicals Ltd. Kokad Pharmaceutical Laboratories Ltd. Infutec Healthcare Ltd. Axa Parenterals Ltd. Ahlcon Parenterals (India) Ltd. Abaris Healthcare Pvt. Ltd. Pharmazell (India) Pvt. Ltd.
Plant capacity: IV Fluids (500 ml Size Pack): 80,000 Packs / Day IV Fluids (100 ml Size Pack): 80,000 Packs / DayPlant & machinery: Rs 2592 lakhs
Working capital: -T.C.I: Cost of Project: Rs 3903 lakhs
Return: 25.00%Break even: 40.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 4 of 5 | Total 49 projects in this category
« Previous   Page 1 2 3 4 5   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top